We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00085332
First Posted: June 11, 2004
Last Update Posted: January 13, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Gynecologic Oncology Group
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: No date given
  Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)
Publications: